- Uro-gynecological surgical devices, designed for the diagnosis and treatment of pelvic floor disorders, urinary incontinence, and pelvic organ prolapse, are critical tools in women’s health and minimally invasive gynecologic surgery, used extensively in both hospitals and ambulatory surgical centers for their precision and patient recovery benefits
- The growing demand for these devices is primarily driven by the increasing global incidence of uro-gynecological conditions, greater awareness of available treatment options, and technological advancements such as robotic-assisted surgery and enhanced mesh materials
- North America dominated the uro-gynecological surgical devices market with the largest revenue share of 39.2% in 2024, supported by a well-established healthcare infrastructure, early adoption of advanced surgical techniques, and strong presence of leading medical device manufacturers, particularly in the U.S. where procedural volumes remain high
- Asia-Pacific is expected to be the fastest growing region during the forecast period due to rising healthcare investments, growing awareness of women’s health issues, and increasing access to surgical care in emerging economies
- Urological surgical devices segment dominates the uro-gynecological surgical devices market with a market share of 46.8% in 2024, driven by its widespread application in treating urinary incontinence and pelvic organ prolapse, along with continuous advancements in minimally invasive surgical tool
